Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke

  • Erlandson, Erika (PI)
  • Sawaki Adams, Lumy (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/9/1510/30/17